|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02427 GUANZE MEDICAL
Nominal 
0.380 -0.070 (-15.556%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 40,030 | -46.206% | 74,413 | 98,621 | 106,728 |
| Cost of Sales | (18,150) | -41.797% | (31,184) | (58,995) | (70,340) |
| Gross Profit | 21,880 | -49.386% | 43,229 | 39,626 | 36,388 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 2,801 | -87.720% | 22,809 | 21,494 | 16,033 | |
| Taxation | (2,938) | -56.038% | (6,683) | (6,092) | (4,866) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (23) | -87.079% | (178) | (86) | (72) | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (160) | -- | 15,948 | 15,316 | 11,095 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (335) | -- | 291 | 633 | 292 |
| Depreciation & Amortisation | 3,300 | 26.972% | 2,599 | 2,563 | 2,088 |
| Directors' Emoluments | -- | -- | -- | 117 | 117 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | Unqualified | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -0.020 | -- | 1.700 | 2.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.254 | -- | 0.271 | -- | -- |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -160,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.000 |
| NBV Per Share (¥) | RMB 0.254 |